CLIFFORD SWAN INVESTMENT COUNSEL LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1034642
PASADENA, CA
Position in BMY
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$16,930,657
-$1,353,194 QoQ
Shares Held
293,833
-2.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#300
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CLIFFORD SWAN INVESTMENT COUNSEL LLC holds $170,286,954 across 10 Drug Manufacturers - General names. BMY ranks #3 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
207,571 | $52,716,806 | |
| 2 | ABBV |
AbbVie Inc.
|
145,173 | $36,531,333 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
293,833 | $16,930,657 | |
| 4 | NVO |
Novo Nordisk A S
|
318,484 | $15,268,122 | |
| 5 | AMGN |
Amgen Inc
|
36,058 | $13,057,322 | |
| 6 | PFE |
Pfizer Inc
|
458,641 | $11,044,075 | |
| 7 | MRK |
Merck & Co., Inc.
|
75,680 | $9,724,880 | |
| 8 | NVS |
Novartis AG
|
60,118 | $9,421,692 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,930,657 | 293,833 | Shares | Other | 2026-08-20 | |
| 2026-03-31 | $18,283,851 | 301,465 | Shares | Other | 2026-05-06 | |
| 2025-12-31 | $16,694,052 | 309,493 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $14,703,862 | 326,028 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $16,108,919 | 348,000 | Shares | Other | 2025-07-30 | |
| 2025-03-31 | $24,444,486 | 400,795 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $24,153,269 | 427,038 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $23,651,181 | 457,116 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $16,843,695 | 405,579 | Shares | Other | 2024-08-07 | |
| 2024-03-31 | $22,837,771 | 421,128 | Shares | Other | 2024-04-17 | |
| 2023-12-31 | $21,746,408 | 423,824 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $25,464,875 | 438,747 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $28,201,822 | 440,998 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $30,833,731 | 444,867 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $32,196,329 | 447,482 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $33,387,276 | 469,648 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $38,109,071 | 494,923 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $36,898,188 | 505,247 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $32,764,239 | 525,489 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $31,070,936 | 525,113 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $34,818,766 | 521,083 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $32,895,212 | 521,071 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $32,269,060 | 520,217 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $32,210,535 | 534,260 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $31,421,426 | 534,378 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $30,050,827 | 539,125 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||